Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Cell Genesys
Man
Between 18 years
and 99 years
Cell Genesys
Update Il y a 4 ans
Cell Genesys VITAL-2 : Essai de phase 3 randomisé comparant un traitement associant docétaxel, et une immunothérapie par GVAX à une chimiothérapie par docétaxel et prédnisone chez des patients ayant un cancer de la prostate. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
A phase III randomized open-label study of docetaxel in combination with CG1940 and CG8711 versus docetaxel and prednisone in taxane-naïve patients with metastatic hormone-refractory prostate cancer w...
Country
France
organs
Prostate
Specialty
Chimiothérapie
,
Immunothérapie - Vaccinothérapie
Essai clos aux inclusions
More information
Man Max 99 years
Cell Genesys Inc
Update Il y a 4 ans
A Phase III Randomized, Open-Label Study of CG1940 and CG8711 Versus Docetaxel and Prednisone in Patients with Metastatic Hormone-Refractory Prostate Cancer who are Chemotherapy-Naïve
The primary objective of this study is to compare the duration of survival between the two treatment arms.
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Cell Genesys Inc
Update Il y a 4 ans
A Phase 3 Randomized, Open-Label Study of Docetaxel in Combination with CG1940 and CG8711 versus Docetaxel and Prednisone in Taxane-Naïve Patients with Metastatic Hormone-Refractory Prostate Cancer With Pain
The primary objective of this study is to compare the duration of survival between the two treatment arms.
Country
None
organs
None
Specialty
None
unknown
More information